Point72 Asset Management
PMVP icon

Point72 Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History

Point72 Asset Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26K Sell
20,945
-7,799
-27% -$9.92K ﹤0.01% 3680
2025
Q4 		$35.9K Buy
+28,744
New +$38.5K ﹤0.01% 3805
2024
Q2 		– Sell
-205,855
Closed -$350K – 2324
2024
Q1 		$350K Sell
205,855
-544,298
-73% -$1.02M ﹤0.01% 1738
2023
Q4 		$2.33M Buy
+750,153
New +$1.99M 0.01% 1152
2023
Q2 		– Sell
-38,178
Closed -$182K – 2654
2023
Q1 		$182K Buy
+38,178
New +$269K ﹤0.01% 1509

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asset Management's PMVP Position: Q1 2026 in Review

Point72 Asset Management reduced its PMV Pharmaceuticals (PMVP) stake by 27% in Q1 2026, selling an estimated $9.92K and leaving 20,945 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3680.

Point72 Asset Management first reported a position in PMVP in Q1 2023 and has held it in 5 quarters since. The position peaked at $2.33M in Q4 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Point72 Asset Management held 20,945 shares of PMV Pharmaceuticals worth $26K as of Q1 2026.
  • Point72 Asset Management sold 7,799 PMV Pharmaceuticals shares in Q1 2026, an estimated $9.92K.
  • PMV Pharmaceuticals made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3680 holding.
  • Point72 Asset Management first reported a position in PMV Pharmaceuticals in Q1 2023 and has held it in 5 quarters since.
  • Point72 Asset Management's PMV Pharmaceuticals position peaked at $2.33M in Q4 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.